HORSHAM, Pa., March 29, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fiscal 2017 financial results on Monday, April 2, before the market opens. STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 8:30 am Eastern Time to review the Company’s progress.
|Conference Call Details:|
|Date:||Monday, April 2|
|Time:||8:30 am Eastern Time|
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.
|Frank McCaney, Chief Executive Officer||Bob Yedid, Managing Director|
|STRATA Skin Sciences, Inc.||LifeSci Advisors, LLC|
Source:STRATA Skin Sciences, Inc.